Utility of prostaglandin analogues and phosphodiesterase inhibitors as promising last resorts for the treatment of vitiligo: A systematic review, from mechanisms of action to mono‐, combination and comparative therapies

Documents similaires

• New variants of COVID‐19 (XBB.1.5 and XBB.1.16, the “Arcturus”): A review of highly questioned concerns, a brief comparison between different peaks in the COVID‐19 pandemic, with a focused systematic review on expert recommendations for prevention, vaccination, and treatment measures in the general population and at‐risk groups
  par: Homa Pourriyahi, et autres
  Publié: (2024)
• Efficacy and Safety of Topical Dapsone in Dermatology: A Scoping Review of Clinical Studies
  par: Bahareh Abtahi‐Naeini, et autres
  Publié: (2025)
• Addressing Methodological Concerns in PRP Treatment for Lichen Planopilaris: A Response to Willaert et al.
  par: Abbas Dehghani, et autres
  Publié: (2025)
• A Systematic Review of Case Series and Clinical Trials Investigating Regenerative Medicine for the Treatment of Vitiligo
  par: Alireza Jafarzadeh, et autres
  Publié: (2024)
• Keloid Formation and Any Skin Complications in Patients Treated With Isotretinoin and Undergone Any Skin‐Related Procedures
  par: Raha Latifaltojar, et autres
  Publié: (2024)